nach oben

Diabetologia

Erschienen in:

01.10.2011 | Commentary

EnRAGEd about death in type 1 diabetes

verfasst von: T. J. Orchard

Erschienen in: Diabetologia | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Excerpt

The mortality rate for those with type 1 diabetes has declined quite remarkably over the last decades. Recent data from Allegheny County (PA, USA) suggest a 33% fall in the 30-year mortality rates for those diagnosed with type 1 diabetes as children in the late 1970s, compared with those diagnosed in the early 1960s [1]. Declines have also been reported from Europe [2, 3]. Much of this improvement probably reflects better diabetes management, spurred on by the demonstration of the long-term value of intensive glycaemic management [4, 5] and the advent of self-monitoring of blood glucose and HbA_1c testing. Nonetheless, mortality still remains five to six times higher for those with type 1 diabetes [1] compared with an age-matched community population, and much work remains to be done. …

Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ (2010) All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes Care 33:2573–2579PubMed

McNally PG, Raymond NT, Burden MI et al (1995) Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in Leicestershire: 1940–1991. Diabet Med 12:961–966PubMed

Borch-Johnsen K (1999) Improving prognosis of type 1 diabetes. Mortality, accidents, and impact on insurance. Diabetes Care 22(suppl 2):B1–B3PubMed

The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

Nathan DM, Cleary PA, Jye-Yu C et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653PubMed

Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ (2010) Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 59:3216–3222PubMed

Pambianco G, Costacou T, Orchard TJ (2007) the prediction of major outcomes of type 1 diabetes: a 12 year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: The Pittsburgh EDC Experience. Diabetes Care 30:1248–1254PubMed

Groop PH, Thomas MC, Moran JL et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658PubMed

Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20-year mortality risk in type 1 diabetes is comparable to that of the generation population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312–2319PubMed

10.

Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMed

11.

Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without nephropathy: incidence and risk factors. Diabetologia 30:144–148PubMed

12.

Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785–794PubMed

13.

Orchard TJ, Costacou T, Kretowski A, Nesto RW (2006) Type 1 diabetes and coronary artery disease. Diabetes Care 29:2528–2538PubMed

14.

Wadwa RP, Kinney GL, Maahs DM et al (2005) Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 28:1051–1060PubMed

15.

Yu Y, Thorpe SR, Jenkins AJ et al (2006) Advanced glycation end-products and methionine sulfoxide in skin collagen in type 1 diabetes. Diabetologia 49:2488–2498PubMed

16.

Monnier VM, Bautista O, Kenny DR et al (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive vs conventional therapy of type 1 diabetes: relevance of glycated collagen products vs HbA_1c as markers of diabetic complications. Diabetes 48:870–880PubMed

17.

Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597–605PubMed

18.

Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC (2011) Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in type 2 diabetes. Clin Sci (Lond) 120:81–89

19.

Falcone C, Emanuele E, D’Angelo A et al (2005) Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 25:1032–1037PubMed

20.

Lindsey JB, de Lemos JA, Cipollone F et al (2009) Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study. Diabetes Care 32:1218–1220PubMed

21.

Thomas MC, Söderlund J, Lehto M et al (2011) Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia doi:10.1007/s00125-011-2186-5

22.

Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L et al (2010) Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New roles for soluble RAGE. Eur J Heart Fail 12:1092–1100PubMed

23.

Semba RD, Ferrucci L, Fink JC et al (2009) Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am J Kidney Dis 53:51–58PubMed

24.

Comper WD, Haraldsson B, Deen WM (2008) Resolved: normal glomeruli filter nephrotic levels of albumin. J Am Soc Nephrol 19:427–432PubMed

25.

Conway BN, Aroda VR, Maynard JD et al (2011) Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care 34:1000–1005PubMed

26.

Conway B, Edmundowicz D, Matter N, Maynard J, Orchard T (2010) Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 12:339–345PubMed

27.

Sun JK, Keenan HA, Cavallerano JD et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration. The Joslin 50-Year Medalist Study. Diabetes Care 34:968–974PubMed

28.

Nin JW, Jorsal A, Ferreira I et al (2011) Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes. A 12-year follow-up study. Diabetes Care 34:442–447PubMed

29.

Grossin N, Boulanger E, Wautier MP, Wautier JL (2010) The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents. Clin Hemorheol Microcirc 45:143–153

Titel: EnRAGEd about death in type 1 diabetes
verfasst von: T. J. Orchard
Publikationsdatum: 01.10.2011
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2229-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2011

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes